{
    "clinical_study": {
        "@rank": "30170", 
        "arm_group": [
            {
                "arm_group_label": "Rem group", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients in this group receive single infusion of remifentanil with target concentration infusion."
            }, 
            {
                "arm_group_label": "Flur group", 
                "arm_group_type": "Experimental", 
                "description": "Patients in this group receive both infusion of flurbiprofen and remifentanil"
            }
        ], 
        "brief_summary": {
            "textblock": "Extracorporeal shock wave lithotripsy (ESWL) of pancreatic stones has been described as an\n      effective approach for stone drainage and pain relief, and general or epidural anesthesia\n      has been reported for such procedure. Single infusion of remifentanil has been described in\n      ESWL of urinary stones, but it has never been described in ESWL of pancreatic stones.\n      Moreover, single infusion of remifentanil might induce several complications, such as\n      postoperative nausea and vomiting. The investigators attended to investigated whether\n      combination of flurbiprofen with remifentanil reduced remifentanil dose and attenuated the\n      complications."
        }, 
        "brief_title": "Combination of Remifentanil and Flurbiprofen in Sedation and Analgesia for ESWL of Pancreatic Stone", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Pancreatic Stone Disease", 
        "condition_browse": {
            "mesh_term": "Calculi"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  aged 18-65 years\n\n          -  ASA I-II\n\n          -  ESWL indication was met\n\n        Exclusion Criteria:\n\n          -  patients with hypertension\n\n          -  patients compromised in cardiopulmonary function\n\n          -  patients undergoing ESWL for the second or more times"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01998217", 
            "org_study_id": "Rem-ESWL-Pancreas"
        }, 
        "intervention": [
            {
                "arm_group_label": "Rem group", 
                "description": "Patients in Rem group receive sedation and analgesia with remifentanil, dose of which will be determined by the up-and-down method.", 
                "intervention_name": "Remifentanil", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Flur group", 
                "description": "Patients in this group receive sedation and analgesia with flurbiprofen and remifentanil, dose of which was determined by the up-and-down method.", 
                "intervention_name": "Flurbiprofen and remifentanil", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Flurbiprofen", 
                "Remifentanil"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "extracorporeal shock wave lithotripsy", 
            "remifentanil", 
            "flurbiprofen", 
            "pancreatic stone"
        ], 
        "lastchanged_date": "November 23, 2013", 
        "location": {
            "contact": {
                "email": "feng_smmu@hotmail.com", 
                "last_name": "Jia-feng Wang, M.D.", 
                "phone": "+86-21-31161853"
            }, 
            "facility": {
                "address": {
                    "city": "Shanghai", 
                    "country": "China", 
                    "state": "Shanghai", 
                    "zip": "200433"
                }, 
                "name": "Department of Anesthesiology, Changhai Hospital"
            }, 
            "investigator": {
                "last_name": "Jia-feng Wang, M.D.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "other_outcome": {
            "description": "The side effects including postoperative nausea and vomiting, as well as pruritus.", 
            "measure": "Side effects", 
            "safety_issue": "No", 
            "time_frame": "within 24 hours after ESWL procedure"
        }, 
        "overall_contact": {
            "email": "feng_smmu@hotmail.com", 
            "last_name": "Jia-feng Wang, M.D.", 
            "phone": "+86-21-31161853"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Visual analogue score of pain", 
            "safety_issue": "No", 
            "time_frame": "During ESWL procedure"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01998217"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Changhai Hospital", 
            "investigator_full_name": "Jia-feng Wang", 
            "investigator_title": "M.D.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Cardiovascular responses including blood pressure and heart rate", 
            "safety_issue": "No", 
            "time_frame": "During ESWL procedure"
        }, 
        "source": "Changhai Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Changhai Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}